The HDA Traceability Seminar commenced with a full audience and a prevailing message woven into the presentations: The FDA’s release of the DSCSA EDDS guidance on Friday, August 25th, should not be seen merely as a period of enforcement discretion. Instead, it signifies a crucial stabilization phase that extends until November 27, 2024. Leigh Verbois […]

The post Pharma Industry Response To DSCSA EDDS Stabilization Period first appeared on World Pharma Today.